Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MTFB.L (MTFB) Share News

12345

WINNERS & LOSERS SUMMARY: Inmarsat Up As Private Equity Firms Make Bid

20th Mar 2019 10:31

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - Group, up 1.1%. The telecommunications was Read More

Amphion Innovations Sells More Shares In Motif Bio As Loan Repayment (ALLISS)

19th Mar 2019 16:20

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it sold 3.3 million shares in its Motif Bio PLC partner company as a partial loan repayment.Amphion Innovations develops and Read More

Motif Bio Chair Morgan Stands Down, Williams Becomes Interim Chair

18th Mar 2019 11:46

LONDON (Alliance News) - Motif Bio PLC said Monday Chair Richard Morgan had resigned from the biopharmaceutical firm, to be replaced by biopharma veteran Bruce Williams as interim - who also as of Read More

Amphion Innovations Sells Partner's Motif Bio Shares In Loan Repayment (ALLISS)

15th Mar 2019 09:26

LONDON (Alliance News) - Amphion Innovations PLC on Friday said it sold 1.8 million shares in partner pharmaceutical company Motif Bio PLC to repay a loan facility.Amphion made USD144,000 Read More

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

11th Mar 2019 18:11

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to Read More

WINNERS & LOSERS SUMMARY: Reckitt Rises After Strong Annual Results

18th Feb 2019 10:43

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Reckitt its Read More

Motif Bio Will Need Fundraise After Agreeing To Repay Part of Loan

18th Feb 2019 09:27

LONDON (Alliance News) - Shares in Motif Bio PLC plunged on Monday as its subsidiary, Motif Biosciences Inc signed an amendment agreement with lender Hercules Capital Inc over a loan agreement in Read More

Invesco Lowers Motif Bio Interest By More Than 10% (ALLISS)

15th Feb 2019 16:34

LONDON (Alliance News) - Motif Bio PLC on Friday said that Invesco Ltd has cut its stake in the company by more than 10%.Prior to Friday's deal, Invesco held a 24.98% interest in the it Read More

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

14th Feb 2019 11:17

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up Read More

Motif Bio Receives GBP36,500 Following Warrants Exercise (ALLISS)

5th Feb 2019 10:56

LONDON (Alliance News) - Motif Bio PLC on Tuesday said it has netted GBP36,514 following the exercise of share warrants.The pharmaceutical company said 113,396 warrants were exercised at a Read More

Amphion Innovations Restructures Loan And Agrees Further Drawdown

16th Oct 2018 11:38

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it has restructured its loan payments and agreed a further USD1.1 million draw-down.Amphion's shares dropped 12% to 0.66 Read More

Amphion Innovations Sells Motif Bio Shares To Repay Loan Facility (ALLISS)

21st Aug 2018 10:50

LONDON (Alliance News) - Amphion Innovations PLC said Tuesday it sold 3 million shares in Motif Bio PLC to institutional investors at 33.5 pence each, lowering its stake in the company to company Read More

Motif Bio Gets Patent Permission In US For Antibiotic Iclaprim

8th Aug 2018 12:28

LONDON (Alliance News) - Motif Bio PLC said Wednesday it has been given a Notice of Allowance from the US Patent & Trademark Office for use of its antibiotic, iclaprim, to treat bacterial that Read More

Motif Bio Director Robert Bertoldi To Resign From Role July 16

3rd Jul 2018 10:47

LONDON (Alliance News) - Clinical-stage biopharmaceutical company Motif Bio PLC said Tuesday that Director Robert Bertoldi will resign from the board with effect on July 16.Chief Executive Read More

Amphion Sells 8.9 Million Shares In Motif Bio To Repay Loan Facility (ALLISS)

23rd May 2018 14:39

LONDON (Alliance News) - Amphion Innovations PLC said on Wednesday it sold 8.9 million shares in partner company Motif Bio PLC to partially repay a loan facility, as well as to fund ongoing & Read More

UPDATE: Motif Bio Completes GBP10 Million Fundraise Through Placing (ALLISS)

17th May 2018 14:56

LONDON (Alliance News) - Biopharmaceutical firm Motif Bio PLC said it has successfully raised GBP10 million via an accelerated bookbuild exercise on Thursday.The company placed 32.3 million Read More

Motif Bio To Raise GBP10 Million Via Accelerated Share Bookbuild (ALLISS)

17th May 2018 12:20

LONDON (Alliance News) - Motif Bio PLC said it plans to raise GBP10 million via an accelerated bookbuild exercise, which will launch on Thursday.The funds raised will be used by the company Read More

Motif Bio's Iclaprim Delivers Continued Good Test Results

19th Apr 2018 13:59

LONDON (Alliance News) - Motif Bio PLC on Thursday said iclaprim delivered further positive results as part of its REVIVE-2 phase three trial.Motif Bio previously had said iclaprim showed a Read More

Motif Bio Delays Iclaprim New Drug Application, Shares Fall

20th Mar 2018 11:08

LONDON (Alliance News) - Motif Bio PLC's shares fell on Tuesday as the biopharmaceutical company said it has pushed back the date for its new drug application submission a Read More

Motif Bio Issues 178,571 Shares Following Warrants Exercise (ALLISS)

7th Mar 2018 13:24

LONDON (Alliance News) - Motif Bio PLC said Wednesday it has raised GBP57,499 through the issue of 178,571 shares at a price of 32.2 pence per of Read More

12345
FTSE 100 Latest
Value8,407.44
Change4.26